CyberKnife Society Receives Record Registration for 7th Annual CyberKnife Users'...

CyberKnife Society Receives Record Registration for 7th Annual CyberKnife
Users' Meeting
More than 500 Healthcare Specialists to Convene in Arizona to Share Expertise

SUNNYVALE, Calif., Jan. 15 /PRNewswire-FirstCall/ -- Accuray Incorporated
(Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today
that more than 500 medical, clinical and technical specialists have registered
for the 7th Annual CyberKnife Users' Meeting, January 23-27, 2008 in
Scottsdale, Ariz.
Over the past seven years, Accuray has seen consistent growth in the
number of users attending the meeting, beginning with just 27 users at the
first meeting in 2001. The 7th Annual Meeting demonstrated not only record
registration, but also a record number of presentation and poster abstracts
submitted for consideration.
"We're thrilled with the tremendous amount of interest we've received
around this year's Users' Meeting from presenters and attendees alike," said
Eric P. Lindquist, senior vice president and chief marketing officer of
Accuray Incorporated. "Taking into account clinicians' busy schedules, we
feel the robust attendance anticipated at this year's Users' Meeting shows the
clinical value of the event and the growing role CyberKnife radiosurgery is
playing in cancer care."
Unlike many other technologies' Users' meetings, the CyberKnife Users'
Meeting is uniquely focused on delivering concentrated clinical material
presented by CyberKnife users in various fields. For this reason a maximum of
26 continuing medical education (CME) credits(TM), accredited through
Georgetown University Hospital, will be offered to participating physicians.
This year's meeting will feature more than 70 clinical and technical
presentations selected by a scientific panel of users, as well as more than 70
scientific posters, focusing on intracranial and extracranial experience and
treatment outcomes from CyberKnife users worldwide. In addition, specialized
sessions will be offered focusing on coding and reimbursement, business
development and marketing, patient management and efficiencies, and physics,
along with tumor review board interactive panel discussions.
The CyberKnife Users' Meeting is organized by the CyberKnife Society, an
organization that brings together users from around the world to foster the
scholarly exchange of information pertaining to CyberKnife radiosurgery.
Attendees include leading surgeons, radiation oncologists, radiation
therapists, physicists, administrators and nurses from around the world.
Attendance at the CyberKnife Users' Meeting is typically self-funded for both
attendees and presenters alike.
About the CyberKnife(R) Robotic Radiosurgery System
The CyberKnife Robotic Radiosurgery System is the world's only robotic
radiosurgery system designed to treat tumors anywhere in the body
non-invasively. Using continual image guidance technology and computer
controlled robotic mobility, the CyberKnife System automatically tracks,
detects and corrects for tumor and patient movement in real-time throughout
the treatment. This enables the CyberKnife System to deliver high-dose
radiation with pinpoint precision, which minimizes damage to surrounding
healthy tissue and eliminates the need for invasive head or body stabilization
frames.
About Accuray
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a
global leader in the field of radiosurgery dedicated to providing an improved
quality of life and a non-surgical treatment option for those diagnosed with
cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery
System, which extends the benefits of radiosurgery to include extracranial
tumors, including those in the spine, lung, prostate, liver and pancreas. To
date, the CyberKnife System has been used to treat more than 40,000 patients
worldwide and currently more than 100 systems have been installed in leading
hospitals in the Americas, Europe and Asia. For more information, please
visit www.accuray.com.
CME Statement
Georgetown University Hospital is accredited by the Accreditation Council
for Continuing Medical Education to provide continuing medical education for
physicians. Georgetown University Hospital designates this educational
activity for a maximum of 26 hours AMA PRA Category 1 Credits(TM). Each
physician should claim only those hours of credit that he/she actually spent
in the education activity.
Safe Harbor Statement
The foregoing may contain certain forward-looking statements that involve
risks and uncertainties, including uncertainties associated with the medical
device industry. Except for the historical information contained herein, the
matters set forth in this press release, clinical studies, regulatory review
and approval, and commercialization of products are forward-looking statements
within the meaning of the "safe harbor" provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements speak only as of
the date the statements are made and are based on information available at the
time those statements are made and/or management's good faith belief as of
that time with respect to future events. You should not put undue reliance on
any forward-looking statements. Important factors that could cause actual
performance and results to differ materially from the forward-looking
statements we make include: market acceptance of products; competing products,
the combination of our products with complementary technology; and other risks
detailed from time to time under the heading "Risk Factors" in our report on
Form 10-Q for the quarterly period ended September 29, 2007 and may be updated
from time to time by our other filings with the Securities and Exchange
Commission. The Company's actual results of operations may differ
significantly from those contemplated by such forward-looking statements as a
result of these and other factors. We assume no obligation to update
forward-looking statements to reflect actual performance or results, changes
in assumptions or changes in other factors affecting forward-looking
information, except to the extent required by applicable securities laws.
SOURCE Accuray Incorporated

Susan Lehman of Rockpoint Public Relations, +1-510-832-6006,
susan@rockpointpr.com, for Accuray; or Stephanie Tomei, Public Relations
Manager of Accuray Incorporated, +1-408-789-4234, stomei@accuray.com